Treatment of periodontal intrabony defects using autologous periodontal ligament stem cells: a randomized clinical trial

• Published in: Stem cell research & therapy Vol. 7; no. 1; p. 33
• Main Authors: Chen, Fa-Ming, Gao, Li-Na, Tian, Bei-Min, Zhang, Xi-Yu, Zhang, Yong-Jie, Dong, Guang-Ying, Lu, Hong, Chu, Qing, Xu, Jie, Yu, Yang, Wu, Rui-Xin, Yin, Yuan, Shi, Songtao, Jin, Yan
• Format: Journal Article
• Language: English
• Published: London BioMed Central 19.02.2016; BioMed Central Ltd; BMC
• Subjects: Adolescent; Adult; Adult Stem Cells - physiology; Aged; Biomedical and Life Sciences; Biomedical Engineering and Bioengineering; Bone Regeneration; Care and treatment; Cell Biology; Cell sheet; Cells, Cultured; Clinical trials; Complications and side effects; Development and progression; Female; Humans; Jaw Diseases - diagnostic imaging; Jaw Diseases - therapy; Life Sciences; Male; Middle Aged; Periodontal Ligament - pathology; Periodontal regeneration; Periodontitis; Periodontitis - diagnostic imaging; Periodontitis - therapy; Radiography; Regenerative Medicine; Regenerative Medicine/Tissue Engineering; Stem Cell Transplantation; Stem cell-therapy; Stem Cells; Tissue engineering; Tooth Socket - diagnostic imaging; Tooth Socket - pathology; Translational medicine; Transplantation; Transplantation, Autologous; Treatment Outcome; Young Adult; United States; Periodontal regeneration; Cell sheet; Periodontitis; Tissue engineering; Stem cell-therapy; Translational medicine
• ISSN: 1757-6512; 1757-6512
• DOI: 10.1186/s13287-016-0288-1

Background Periodontitis, which progressively destroys tooth-supporting structures, is one of the most widespread infectious diseases and the leading cause of tooth loss in adults. Evidence from preclinical trials and small-scale pilot clinical studies indicates that stem cells derived from periodontal ligament tissues are a promising therapy for the regeneration of lost/damaged periodontal tissue. This study assessed the safety and feasibility of using autologous periodontal ligament stem cells (PDLSCs) as an adjuvant to grafting materials in guided tissue regeneration (GTR) to treat periodontal intrabony defects. Our data provide primary clinical evidence for the efficacy of cell transplantation in regenerative dentistry. Methods We conducted a single-center, randomized trial that used autologous PDLSCs in combination with bovine-derived bone mineral materials to treat periodontal intrabony defects. Enrolled patients were randomly assigned to either the Cell group (treatment with GTR and PDLSC sheets in combination with Bio-oss ® ) or the Control group (treatment with GTR and Bio-oss ® without stem cells). During a 12-month follow-up study, we evaluated the frequency and extent of adverse events. For the assessment of treatment efficacy, the primary outcome was based on the magnitude of alveolar bone regeneration following the surgical procedure. Results A total of 30 periodontitis patients aged 18 to 65 years (48 testing teeth with periodontal intrabony defects) who satisfied our inclusion and exclusion criteria were enrolled in the study and randomly assigned to the Cell group or the Control group. A total of 21 teeth were treated in the Control group and 20 teeth were treated in the Cell group. All patients received surgery and a clinical evaluation. No clinical safety problems that could be attributed to the investigational PDLSCs were identified. Each group showed a significant increase in the alveolar bone height (decrease in the bone-defect depth) over time ( p  < 0.001). However, no statistically significant differences were detected between the Cell group and the Control group ( p  > 0.05). Conclusions This study demonstrates that using autologous PDLSCs to treat periodontal intrabony defects is safe and does not produce significant adverse effects. The efficacy of cell-based periodontal therapy requires further validation by multicenter, randomized controlled studies with an increased sample size. Trial Registration NCT01357785 Date registered: 18 May 2011.